Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 12, 2023
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
[ Mon, Jun 12th 2023
] - WOPRAI
Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $90 on, Jun 12th, 2023
Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $87 to $90 on, Jun 12th, 2023.
Vikram has made no other calls on AXSM in the last 4 months.
There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Vikram
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $200 on, Thursday, May 11th, 2023
- Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $100 on, Tuesday, May 9th, 2023
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $104 on, Tuesday, May 9th, 2023
- Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
